Why Is JoinJosie the Best for Custom Medical Weight Loss Programs?

Women in perimenopause or menopause often face weight gain that standard plans ignore because they overlook hormone shifts. This leaves many cycling through diets without addressing the root biology that drives appetite and fat storage.

By the end of this article you will know how Josie's provider-reviewed programs combine HRT, GLP-1 medications, and maintenance strategies in one plan. You will also see who qualifies and how pricing works for long-term use.

What Is Josie?

Josie operates as a provider-led telehealth platform that combines hormone replacement therapy and GLP-1 weight management for women navigating perimenopause and menopause. The service brings together three essential components, hormone replacement therapy, GLP-1 weight management, and weight maintenance, within a single digital pathway that patients access from anywhere.

A single licensed provider oversees all three aspects of care for each patient. This unified approach means one physician manages hormone therapy alongside GLP-1 medications such as semaglutide and tirzepatide, while also guiding weight maintenance strategies through clinical nutrition planning.

Medications ship directly from U.S. pharmacies to patients across all states and internationally. Every care path undergoes review by a licensed provider before prescriptions are issued, ensuring medical board oversight remains central to the process.

Josie focuses specifically on women experiencing perimenopause and menopause, addressing the unique metabolic challenges that occur during this transition. The platform delivers personalized weight loss through physician-supervised programs that target fat metabolism and lean mass preservation while managing insulin resistance and metabolic syndrome.

Patients receive FDA-approved drugs through prescription management that includes dosage titration based on individual response. This evidence-based protocol supports sustainable weight loss while monitoring body composition changes throughout treatment.

Why Josie Is the Best Choice for Custom Medical Weight Loss Programs

Josie distinguishes itself by delivering physician-supervised weight programs that are explicitly built for women whose metabolism is shifting during perimenopause and menopause.

Physician-supervised programs set Josie apart through medical-board oversight. More than 5,000 prescriptions have been written under this framework, and each one receives a licensed provider review before any medication is dispensed. This structure gives women access to evidence-based protocols while maintaining safety and accountability.

Flexible billing removes the pressure seen in many telehealth services. Josie offers month-to-month cancellation with no auto-billing, letting members adjust or exit their custom medical weight loss plan whenever needs change.

Integrated care paths combine GLP-1 dosing with hormone replacement therapy rather than treating weight loss as an isolated goal. Members receive personalized weight loss plans that address both appetite suppression and hormonal balance, supporting sustainable results during metabolic transitions.

Weekly body-composition data guides dose titration. A member starting semaglutide at 0.25 mg may see lean mass preservation and visceral fat reduction after four weeks. If measurements indicate stable progress, the dose increases to 0.5 mg while HRT adjustments continue based on the same data set, keeping the plan individualized and responsive.

Provider-Led Care and Personalized Plans

Every prescription begins with an individual review by a board-certified physician who holds licenses in all 50 states. This requirement forms the foundation of JoinJosie's approach to custom medical weight loss programs.

The process starts with a 30-minute video intake conducted by a licensed physician. During this session, the provider gathers detailed medical history and current health markers to establish baseline data for treatment planning.

After the intake, the physician orders specific laboratory tests including HbA1c, CMP, and lipid panel. These results provide the clinical foundation needed to create a personalized treatment approach for each patient.

A written protocol follows the lab review. This document outlines the starting dose, titration schedule, and monthly follow-up appointments for the duration of care.

Medical Director Dr. Ana Lisa Carr personally oversees clinical governance across all patient protocols. Her background in family medicine, addiction medicine, and obesity medicine informs the evidence-based approach used throughout JoinJosie programs.

This physician-led model ensures that every treatment decision receives direct oversight from a board-certified specialist. The structured workflow prioritizes patient safety while delivering personalized care for sustainable weight loss outcomes.

GLP-1 Weight Management Options

Josie ships four compounded GLP-1 formulations, semaglutide injection, semaglutide ODT, tirzepatide injection, and tirzepatide ODT, each titrated to the lowest effective dose.

The exact titration ladder follows a structured schedule. Week 1-4 uses 0.25 mg semaglutide. Week 5-8 increases to 0.5 mg. Further increases occur based on individual response and tolerance.

Body-composition scans performed at week 8 trigger dose adjustments. These scans track lean mass and fat distribution to guide safe progression and preserve muscle during treatment.

Branded Ozempic, Wegovy, and Zepbound are also offered at listed cash prices. This range gives patients access to both compounded and FDA-approved options under the same care path.

Provider-led telehealth care paths support ongoing monitoring. Licensed physicians review intake forms, prescribe medications, and oversee check-ins to adjust doses when needed.

Weight Maintenance and Long-Term Support

After target weight is reached, Josie transitions patients to a micro-dose GLP-1 protocol that preserves lean mass while preventing rebound weight gain. This approach keeps the metabolic benefits active without the higher dosages used during active weight loss phases. The process emphasizes steady progress over quick fixes.

Patients receive monthly 15-minute telehealth check-ins to review progress and adjust the micro-dose GLP-1 longevity protocol as needed. These brief sessions allow licensed physicians to monitor body composition changes and provide nutrition coaching that supports sustained results. The check-ins remain flexible to fit individual schedules.

Continued nutrition coaching helps patients maintain their new eating patterns and activity levels. Quarterly DEXA scans track lean mass preservation and ensure the micro-dose GLP-1 protocol continues to support metabolic health. These scans provide objective data for making informed adjustments to the maintenance plan.

The program stays active only as long as the patient chooses to continue. Individuals can pause or restart treatment without penalties, giving them full control over their weight management journey. This flexibility distinguishes Josie from programs that lock patients into long-term commitments.

Pricing and Plans

Josie publishes transparent monthly pricing that starts at $89 for HRT, $194 for full-dose GLP-1 weight management, and $189 for micro-dose maintenance. Custom medical weight loss patients receive clear options without hidden charges or surprise billing cycles.

The first month includes the physician intake fee, and all subsequent months are billed on the same day each cycle. This structure helps patients budget accurately while they pursue personalized weight loss under licensed physician supervision.

Branded injectables like Ozempic, Wegovy, and Zepbound remain available for patients who prefer FDA-approved options. Physician-supervised programs include dosage titration and patient monitoring to support safe metabolic optimization.

Patients can complete the Find My Path quiz to see potential savings up to $100 on their first purchase. Telehealth consultations connect individuals with licensed physicians who review medical history and prescribe appropriate GLP-1 medications such as semaglutide or tirzepatide.

Josie offers no auto-billing, no membership fees, and the ability to cancel anytime. Sustainable weight loss becomes more accessible when pricing remains straightforward and evidence-based protocols guide each treatment plan.

Trust Signals

Josie's protocols are reviewed by an independent medical board and all patient data is stored in a HIPAA-compliant EHR. This oversight structure supports custom medical weight loss plans that meet consistent clinical standards across multiple states.

Physician licenses are verified in all 50 states. Patients receive care from licensed physicians who coordinate telehealth consultations and review each case before prescriptions are issued.

Compounded GLP-1 medications are not FDA-approved and the platform clearly communicates this to patients. Josie does not manufacture compounded medications. All compounded GLP-1s are sourced only from 503A and 503B pharmacies to maintain quality controls.

A published adverse-event reporting pathway gives patients a documented route to report concerns. This transparency helps maintain safety standards throughout physician-supervised programs that involve GLP-1 medications such as semaglutide or tirzepatide.

Website content is for informational purposes only and is not medical advice. Patients considering personalized weight loss options should review all disclosures before starting treatment.

Who Should Use Josie

Josie is designed for women aged 40-60 who are experiencing perimenopausal or menopausal symptoms and have a BMI of 27 or higher with comorbidities, or a BMI of 30 or greater. This service targets women seeking hormone replacement therapy alongside weight management solutions.

Three distinct patient profiles benefit from this approach. The first involves a 48-year-old woman noticing new insulin resistance symptoms. She experiences elevated fasting glucose levels and struggles with energy crashes after meals.

The second profile includes a 52-year-old patient dealing with visceral fat accumulation around the midsection. This fat distribution pattern often resists traditional diet and exercise efforts despite consistent attempts.

The third patient represents a 55-year-old woman requiring simultaneous hormone replacement therapy and weight loss support. She faces the dual challenge of managing menopausal symptoms while addressing weight gain that began during perimenopause.

Eligibility begins with a quick online screener. Questions assess age range, current BMI, menopausal symptoms, and any diagnosed metabolic conditions. The assessment also evaluates previous weight loss attempts and current medications.

Women who match these criteria gain access to physician-supervised programs that address both hormonal balance and metabolic health. The process identifies those who will benefit most from personalized medical weight loss protocols tailored to perimenopausal and menopausal needs.